Breaking News, Collaborations & Alliances

Azelis Enters Distribution Agreement with Evonik

Azelis will distribute Evonik’s EUDRAGIT functional polymers in Malaysia and Singapore.

By: Rachel Klemovitch

Assistant Editor

Azelis, a service provider in the specialty chemicals and food ingredients industry, has been appointed exclusive distributor for Evonik’s EUDRAGIT functional polymers in Malaysia and Singapore, effective April 1, 2025.

This partnership strengthens the longstanding relationship between Azelis and Evonik across several market segments around the globe, and within the pharmaceutical industry in the region.

EUDRAGIT functional polymers offer a range of solutions designed for advanced controlled drug delivery in oral solid dosage forms. These polymers enhance the solubility, permeability, and protection of active ingredients throughout the gastrointestinal tract, enabling targeted drug release. 

This expanded partnership helps Evonik streamline its distribution model in the Asia Pacific region. Evonik chose Azelis for its proven track record in India. 

Rapeeporn Sathitthammaporn, Senior Business Manager at Evonik, said: “We’re delighted to strengthen our partnership with Azelis. Their eagerness to grow, agility, and long-term vision align perfectly with Evonik’s mission to provide innovative, effective solutions to the challenges of the future. We believe that their existing expertise and strategic alignment will facilitate the business transition and ensure optimum service to existing and new customers.”

Visava Lertrojanapunya, Regional Managing Director, Southeast Asia at Azelis, commented: “We are grateful to Evonik for their continued trust in Azelis. This partnership aligns with our vision to build a robust pharmaceutical portfolio in Malaysia and Singapore. With our technical expertise, formulation support, and customer-first approach, we are committed to delivering innovative solutions that address the evolving needs of pharmaceutical manufacturers.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters